Table 1.

Characteristics of patients included in the study

	Patient 1	Patient 2	Patient 3	Patient 4
Age (years)	68	83	63	60
LEVF (%)	45–50	30–35	30	15–20
Etiology of  Cardiomyopathy	Nonischemic	Nonischemic	Ischemic	Ischemic
Ablation location	Endocardial ×2	Endocardial  ×1	Endocardial  ×1,  Epicardial  ×1	Endocardial ×2
Timimg of RDN  relative to VT  ablation	Simultaneous to ablation no. 2	4 weeks	postablation	1 year postepicardial ablation
Simultaneous to  ablation no. 2
ICD shocks in the  month Pre-RDN	14	11	5	14
ICD shocks post-  RDN	2	2	4	2
post-RDN Follow-up  Months	10	9	11	14
Pre-Hospitalization  anti Arrhythmic  Agents	Metoprolol ER 100 mg P0 daily	Sotalol  80 mg Po  bid	Amiodarone  200 mg Po  bid	Amiodarone 200 mg P0 daily  Cervedilol 25 mg Po bid
Hospitalization  antiarrhythmic  agent	Lidocaine gtt Esmolol gtt Amiodarone gtt (~2 g  total) Procainamide gtt Amiodarone 200 mg P0  daily Metoprolol ER 150 mg P0 daily Mexifetine  150 mg P0 tid	Sotalol  80 mg P0  bid	Amiodarone  200 mg P0  bid	Amiodarone gtt (~1 g total)  Amiodarone 400 mg P0 daily  Metoprolol ER 200 mg P0 daily
Posthospitalization  antiarrhythmic  agents	Amiodarone 200 mg P0 daily Metoprolol ER 100 mg  P0 daily Mexiletine 150 mg P0 tid	Sotalol  80 mg P0  bid	Amiodarone 200 mg P0  bid	Amiodarone 200 mg P0 bid  Carvedilol 25 mg P0 bid  Metoprolol ER 200 mg P0 daily

ICD = implantable cardioverter defibrillator; LVEF = left ventricular ejection fraction; RDN = renal artery denervation; VT = ventricular tachycardia.